Cartalax 20mg (Bioregulator)

$60.00

Cartalax 20mg is the synthetic Khavinson short-peptide bioregulator derived from cartilage tissue fractions, for in-vitro chondrocyte and cartilage-cell research. Greater than 99 percent HPLC verified.

Peptide Science research editorial team.

Cartalax 20mg (Bioregulator) Overview

Cartalax 20mg from Peptide Science is the synthetic Khavinson short-peptide bioregulator derived from cartilage tissue fractions, supplied as a lyophilised vial for in-vitro and preclinical chondrocyte and cartilage-research applications. The compound is the cartilage-targeted member of the Khavinson short-peptide family.

Khavinson Short-Peptide Class Background

Cartalax belongs to the Khavinson short-peptide family, a class of synthetic two-to-four-residue peptides originally derived from bioregulator-fraction extracts of mammalian tissues by V. Kh. Khavinson and colleagues. The class is characterised by short sequence length (typically 2 to 4 amino acids), organ-specific source-tissue derivation, and synthetic reconstitution of the original tissue-fraction activity. Cartalax is also cross-listed in the anti-aging-bioregulator hybrid taxonomy alongside Epithalon and Cortexin.

Cartilage Bioregulator Research Context

Cartalax is studied in preclinical research for chondrocyte signalling pathways and cartilage-cell regenerative models. The compound supports research on cartilage-tissue regeneration and joint-research models alongside related Khavinson bioregulators targeting connective-tissue and musculoskeletal systems. Browse the broader bioregulator peptide range.

Vial Specifications

Cartalax 20mg research specifications
Property Value
Compound Cartalax
Class Khavinson short-peptide bioregulator
Source-tissue derivation Cartilage tissue fraction
Supplied form Lyophilised powder, sealed vial
Strength 20 mg per vial
Purity greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

For related Khavinson short-peptide bioregulators targeting connective-tissue systems, see Livagen Peptide 20mg or the parent Epithalon 20mg.

Reconstitution and Handling

The lyophilised short peptide reconstitutes with bacteriostatic water at the working concentration set by the principal investigator.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.

Reviews

There are no reviews yet.

Be the first to review “Cartalax 20mg (Bioregulator)”

Your email address will not be published. Required fields are marked *

Scroll to Top